Sign in
4

Changes in Ownership

Royalty Pharma plc Filed Acc 0001802768-25-000107

Director sold 33,500 shares at $36.23 ($1,213,749)

  • Director acquired 144,660 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Norden Gregory Director 2025-08-08 Conversion +144,660 228,348 D
Norden Gregory Director 2025-08-11 Sale −33,500 $36.23 $1,213,749 194,848 D
Derivatives
Norden Gregory Director 2025-08-08 Conversion · LP interests in RPI US Partners 2019, LP −14,466 0 D
Open-market sales · 33,500 sh · avg $36.23 · $1,213,749
Loading xslF345X05/wk-form4_1754944552.xml…